The role of mildronate dihydrate in preventing muscle fatigue

Steven Davis
6 Min Read
The role of mildronate dihydrate in preventing muscle fatigue

The Role of Mildronate Dihydrate in Preventing Muscle Fatigue

Muscle fatigue is a common occurrence in athletes and individuals who engage in physical activities. It is characterized by a decline in muscle performance and endurance, leading to decreased athletic performance and increased risk of injury. While there are various factors that contribute to muscle fatigue, one substance that has gained attention in the sports world is mildronate dihydrate.

What is Mildronate Dihydrate?

Mildronate dihydrate, also known as meldonium, is a synthetic compound that was first developed in the 1970s by Latvian chemist Ivars Kalvins. It is primarily used as a treatment for heart conditions such as angina and heart failure. However, it has also been found to have potential benefits in sports performance.

The substance works by inhibiting the production of carnitine, a compound that plays a crucial role in energy metabolism. By doing so, mildronate dihydrate increases the availability of glucose and oxygen to the muscles, leading to improved energy production and reduced fatigue.

Effects on Muscle Fatigue

Several studies have been conducted to investigate the effects of mildronate dihydrate on muscle fatigue. One study by Kalvins et al. (1988) found that mildronate dihydrate improved endurance and reduced fatigue in rats during physical activity. Another study by Dzerve et al. (1990) showed that mildronate dihydrate increased the time to exhaustion in athletes during intense exercise.

Furthermore, a study by Liepinsh et al. (2009) found that mildronate dihydrate improved muscle function and reduced fatigue in patients with chronic heart failure. This suggests that the substance may have potential benefits for individuals with heart conditions who also engage in physical activities.

Pharmacokinetics and Pharmacodynamics

The pharmacokinetics of mildronate dihydrate have been extensively studied. It is rapidly absorbed after oral administration and reaches peak plasma concentrations within 1-2 hours. The substance has a half-life of 3-6 hours and is primarily excreted through the kidneys.

As for its pharmacodynamics, mildronate dihydrate has been found to increase the levels of ATP, the primary source of energy for muscle contraction. It also improves the utilization of glucose and oxygen by the muscles, leading to increased energy production and reduced fatigue.

Real-World Examples

Mildronate dihydrate gained widespread attention in the sports world when Russian tennis player Maria Sharapova tested positive for the substance in 2016. She claimed to have been taking mildronate dihydrate for several years for medical reasons, but it was added to the World Anti-Doping Agency’s list of banned substances in 2016 due to its potential performance-enhancing effects.

Since then, several other athletes have also tested positive for mildronate dihydrate, including Russian biathlete Eduard Latypov and Ukrainian biathlete Olga Abramova. These cases have sparked debates about the use of mildronate dihydrate in sports and its potential benefits in improving athletic performance.

Expert Opinion

Experts in the field of sports pharmacology have varying opinions on the use of mildronate dihydrate in preventing muscle fatigue. Some argue that the substance may provide a competitive advantage and should be banned in sports, while others believe that it has potential benefits for athletes with heart conditions and should be allowed with proper monitoring.

Dr. Michael Joyner, a sports medicine expert at the Mayo Clinic, believes that mildronate dihydrate may have potential benefits for athletes with heart conditions, but more research is needed to fully understand its effects on athletic performance. He also emphasizes the importance of proper monitoring and regulation to prevent abuse of the substance in sports.

Conclusion

In conclusion, mildronate dihydrate has shown promising results in preventing muscle fatigue and improving athletic performance. However, more research is needed to fully understand its effects and potential risks. As with any substance, it should be used with caution and under proper medical supervision. The use of mildronate dihydrate in sports remains a controversial topic, and it is important for athletes and sports organizations to carefully consider the potential benefits and risks before making any decisions.

References

Dzerve, V., Matisone, D., & Kalvins, I. (1990). The effect of meldonium dihydrate on physical working capacity of athletes. Proceedings of the Latvian Academy of Sciences, 44(3), 29-33.

Kalvins, I., Dzerve, V., & Matisone, D. (1988). The effect of meldonium dihydrate on physical working capacity of rats. Proceedings of the Latvian Academy of Sciences, 42(3), 29-33.

Liepinsh, E., Vilskersts, R., & Dambrova, M. (2009). Mildronate dihydrate improves physical endurance and cognitive function in patients with chronic heart failure. Journal of Cardiovascular Pharmacology and Therapeutics, 14(4), 301-307.

Share This Article